14th International Bordetella Symposium

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F24%3A00587550" target="_blank" >RIV/61388971:_____/24:00587550 - isvavai.cz</a>

Výsledek na webu

<a href="https://event.fourwaves.com/bordetella/pages" target="_blank" >https://event.fourwaves.com/bordetella/pages</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

14th International Bordetella Symposium

Popis výsledku v původním jazyce

This 14th edition of the global International Bordetella Symposium assembled pertussis experts and returned after 62 years to Prague, where the whole meeting series started in 1962, once the Czechoslovak pertussis vaccine has been introduced into pediatric use. The 220 experts from countries covering all continents attending the meeting in person and 72 attendees connecting online, presented and discussed for 5 days research and strategies aiming to counter the current global resurgence of the potentially fatal whooping cough disease. Aspects of the epidemiology, clinical manifestations, vaccination strategies against pertussis and the immunology and basic biology aspects the bacteria of the genus Bordetella that cause respiratory infections in mammals. These topics were duly covered by presentations of the state-of-the -art knowledge on the matter, involving also major global pertussis vaccine manufacturer representatives. The meeting represented a milestone in the global efforts to restrict the current massive resurgence of pertussis disease.nnConference was supported by the National Institute of Virology and Bacteriology (Program EXCELES, ID Project No. LX22NPO5103) funded by the European Union–Next Generation EU.

Název v anglickém jazyce

14th International Bordetella Symposium

Popis výsledku anglicky

This 14th edition of the global International Bordetella Symposium assembled pertussis experts and returned after 62 years to Prague, where the whole meeting series started in 1962, once the Czechoslovak pertussis vaccine has been introduced into pediatric use. The 220 experts from countries covering all continents attending the meeting in person and 72 attendees connecting online, presented and discussed for 5 days research and strategies aiming to counter the current global resurgence of the potentially fatal whooping cough disease. Aspects of the epidemiology, clinical manifestations, vaccination strategies against pertussis and the immunology and basic biology aspects the bacteria of the genus Bordetella that cause respiratory infections in mammals. These topics were duly covered by presentations of the state-of-the -art knowledge on the matter, involving also major global pertussis vaccine manufacturer representatives. The meeting represented a milestone in the global efforts to restrict the current massive resurgence of pertussis disease.nnConference was supported by the National Institute of Virology and Bacteriology (Program EXCELES, ID Project No. LX22NPO5103) funded by the European Union–Next Generation EU.

Druh

M - Uspořádání konference

CEP obor

—

OECD FORD obor

10606 - Microbiology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Místo konání akce

Praha

Stát konání akce

CZ - Česká republika

Datum zahájení akce

—

Datum ukončení akce

—

Celkový počet účastníků

292

Počet zahraničních účastníků

260

Typ akce podle státní přísl. účastníků

WRD - Celosvětová akce